"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to CRGX. [ FAQ on what and how to ask] For non-CRGX questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Anup Radhakrishnan
Headquarter: 835 Industrial Road, Suite 400, San Carlos, CA, United States, 94070
Industry: Biotechnology, Employees: 167
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States. The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumor cells with three B-cell malignancies; and allogeneic platform, a universal vector solution designed to effectively limit immune-based rejection to enable durable response of CAR T-cell therapy. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is based in San Carlos, California.
My Watchlist
